PAVmed Debt to Equity Ratio 2015-2025 | PAVM
Current and historical debt to equity ratio values for PAVmed (PAVM) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. PAVmed debt/equity for the three months ending September 30, 2025 was 0.00.
| PAVmed Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-09-30 | $0.02B | $0.02B | 0.69 |
| 2025-06-30 | $0.02B | $0.03B | 0.56 |
| 2025-03-31 | $0.01B | $0.04B | 0.36 |
| 2024-12-31 | $0.04B | $-0.01B | -5.36 |
| 2024-09-30 | $0.04B | $-0.01B | -4.26 |
| 2024-06-30 | $0.06B | $-0.02B | -3.11 |
| 2024-03-31 | $0.06B | $-0.02B | -2.81 |
| 2023-12-31 | $0.06B | $-0.02B | -2.38 |
| 2023-09-30 | $0.06B | $-0.02B | -3.66 |
| 2023-06-30 | $0.06B | $0.00B | -65.68 |
| 2023-03-31 | $0.05B | $0.01B | 5.04 |
| 2022-12-31 | $0.04B | $0.01B | 3.94 |
| 2022-09-30 | $0.04B | $0.03B | 1.54 |
| 2022-06-30 | $0.04B | $0.04B | 0.99 |
| 2022-03-31 | $0.02B | $0.07B | 0.30 |
| 2021-12-31 | $0.01B | $0.08B | 0.10 |
| 2021-09-30 | $0.01B | $0.04B | 0.22 |
| 2021-06-30 | $0.01B | $0.04B | 0.13 |
| 2021-03-31 | $0.00B | $0.05B | 0.07 |
| 2020-12-31 | $0.02B | $0.00B | -42.81 |
| 2020-09-30 | $0.03B | $-0.02B | -1.71 |
| 2020-06-30 | $0.02B | $-0.01B | -1.69 |
| 2020-03-31 | $0.03B | $-0.02B | -1.62 |
| 2019-12-31 | $0.01B | $-0.01B | -2.56 |
| 2019-09-30 | $0.01B | $0.00B | -2.83 |
| 2019-06-30 | $0.01B | $0.00B | -4.76 |
| 2019-03-31 | $0.01B | $-0.01B | -1.77 |
| 2018-12-31 | $0.01B | $0.00B | -4.43 |
| 2018-09-30 | $0.01B | $0.00B | 1.64 |
| 2018-06-30 | $0.01B | $0.01B | 0.72 |
| 2018-03-31 | $0.00B | $0.00B | 14.17 |
| 2017-12-31 | $0.00B | $0.00B | -1.58 |
| 2017-09-30 | $0.01B | $-0.01B | -1.55 |
| 2017-06-30 | $0.01B | $-0.01B | -1.05 |
| 2017-03-31 | $0.01B | $0.00B | -1.25 |
| 2016-12-31 | $0.00B | $0.00B | -3.73 |
| 2016-09-30 | $0.00B | $0.00B | 0.74 |
| 2016-06-30 | $0.00B | $0.00B | 0.15 |
| 2016-03-31 | $0.00B | $0.00B | -13.40 |
| 2015-12-31 | $0.00B | $0.00B | 0.92 |
| 2015-09-30 | $0.00B | $0.00B | 0.00 |
| 2015-06-30 | $0.00B | $0.00B | 0.00 |
| 2015-03-31 | $0.00B | $0.00B | 0.00 |
| 2014-12-31 | $0.00B | $0.00B | 0.05 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.011B | $0.003B |
| PAVmed Inc. is a medical device company. Its diversified pipeline of products address unmet clinical needs, which consists of CarpX (TM) to treat carpal tunnel syndrome; NextFlo(TM) and NextCath(TM) a disposable infusion pump; PortIO(TM) and NextCath interventional radiology and Caldus (TM) tissue ablation and cardiovascular intervention. PAVmed Inc. is headquartered in New York City. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $205.422B | 23.91 |
| Intuitive Surgical (ISRG) | United States | $175.022B | 67.51 |
| IDEXX Laboratories (IDXX) | United States | $51.088B | 48.95 |
| Edwards Lifesciences (EW) | United States | $44.567B | 29.88 |
| Alcon (ALC) | Switzerland | $38.798B | 26.15 |
| IQVIA Holdings (IQV) | United States | $32.812B | 17.73 |
| Mettler-Toledo (MTD) | United States | $28.067B | 32.27 |
| DexCom (DXCM) | United States | $27.364B | 37.72 |
| STERIS (STE) | Ireland | $24.068B | 24.34 |
| Waters (WAT) | United States | $19.540B | 24.99 |
| Coloplast (CLPBY) | Denmark | $17.286B | 26.45 |
| Hologic (HOLX) | United States | $16.748B | 17.53 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.942B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.849B | 11.49 |
| Penumbra (PEN) | United States | $13.278B | 93.40 |
| Globus Medical (GMED) | United States | $11.723B | 24.60 |
| SARTORIUS (SSSGY) | Germany | $7.976B | 46.32 |
| Masimo (MASI) | United States | $7.241B | 23.20 |
| Glaukos (GKOS) | United States | $6.506B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $6.150B | 19.54 |
| Teleflex (TFX) | United States | $4.694B | 7.48 |
| TransMedics (TMDX) | United States | $4.659B | 55.20 |
| LivaNova (LIVN) | United Kingdom | $3.590B | 19.39 |
| Integer Holdings (ITGR) | United States | $2.994B | 14.06 |
| Veracyte (VCYT) | United States | $2.903B | 33.09 |
| Elekta AB (EKTAY) | Sweden | $2.276B | 21.29 |
| UFP Technologies (UFPT) | United States | $2.047B | 27.03 |
| Alphatec Holdings (ATEC) | United States | $2.007B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.918B | 21.17 |
| Artivion (AORT) | United States | $1.877B | 86.11 |
| Pulse Biosciences (PLSE) | United States | $1.641B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.632B | 0.00 |
| AxoGen (AXGN) | United States | $1.565B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.281B | 0.00 |
| IRadimed (IRMD) | United States | $1.221B | 58.16 |
| OPKO Health (OPK) | United States | $0.937B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.851B | 4.61 |
| SiBone (SIBN) | United States | $0.668B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.661B | 13.19 |
| Alpha Tau Medical (DRTS) | Israel | $0.654B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.611B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.610B | 35.46 |
| Pacific Biosciences Of California (PACB) | United States | $0.556B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.517B | 0.00 |
| NeuroPace (NPCE) | United States | $0.508B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.502B | 13.07 |
| AngioDynamics (ANGO) | United States | $0.440B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.419B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.401B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.351B | 58.53 |
| RxSight (RXST) | United States | $0.340B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.314B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Spectral Diagnostics (EDTXF) | Canada | $0.285B | 0.00 |
| 908 Devices (MASS) | United States | $0.249B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.231B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.184B | 0.00 |
| CVRx (CVRX) | United States | $0.172B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.169B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.166B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.155B | 0.00 |
| Inogen (INGN) | United States | $0.152B | 0.00 |
| LENSAR (LNSR) | United States | $0.148B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.141B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.125B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.124B | 0.00 |
| Hyperfine (HYPR) | United States | $0.111B | 0.00 |
| Neuronetics (STIM) | United States | $0.102B | 0.00 |
| Solana (HSDT) | United States | $0.087B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.081B | 0.00 |
| Positron (POSC) | United States | $0.080B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| InspireMD (NSPR) | United States | $0.075B | 0.00 |
| DarioHealth (DRIO) | United States | $0.070B | 0.00 |
| Accuray (ARAY) | United States | $0.066B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.064B | 0.00 |
| Spectral AI (MDAI) | United States | $0.048B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.043B | 0.00 |
| Precision Optics (POCI) | United States | $0.041B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.027B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.026B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.015B | 0.00 |
| Envoy Medical (COCH) | United States | $0.014B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.013B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.013B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| NexGel (NXGL) | United States | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.009B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENvue Medical (FEED) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |